Graeme Poston

Graeme Poston has held the position of consultant hepato-biliary surgeon since 1990 — initially at the Royal Liverpool University Hospital, and since 2004 at University Hospital Aintree (UHA), Liverpool, UK. He is also Divisional Medical Director and Chairman of the Division of Surgery at the UHA, Chairman of the Liverpool, Mersey and North Cheshire Hepatobiliary Cancer Network, and Director of the Liverpool Supra-regional Hepato-Biliary Centre. Dr Poston enjoys an international reputation in hepato-biliary surgery. To date, he has personally performed over 800 major liver and biliary resections (mainly for metastatic colorectal cancer). His unit at the UHA is one of the largest resectional hepato-biliary practices in the UK, undertaking in excess of 300 major liver resections each year.

Dr Poston qualified at St George’s Hospital Medical School, London, in 1979, subsequently training in surgery at Hammersmith Hospital, London, and St Mary’s Hospital, London, as well as at the Department of Surgery, University of Texas Medical Branch, Galveston, Texas, USA.

Graeme Poston is immediate past-President of the British Association of Surgical Oncology and Chairman of the Cancer Services Committee of the Royal College of Surgeons of England. He is the President-elect of the Association of Upper Gastrointestinal Surgeons of Gt. Britain and Ireland. He is the author of eight textbooks on surgery, most recently Surgical Management of Hepatobiliary and Pancreatic Disorders, The Textbook of Surgical Oncology and Liver Metastases, and over 150 peer-reviewed papers, mainly on the subject of hepato-pancreato-biliary diseases.

In addition to membership of a number of UK and European Organisation for Research and Treatment of Cancer (EORTC) clinical trial committees, Dr Poston is a principal investigator of several ongoing clinical trials in hepato-biliary surgical oncology. Other ongoing research interests include: the use of novel therapies in advanced neuroendocrine tumors of the gut; quality of life issues in advanced gastrointestinal tract cancers and following iatrogenic bile duct injuries; and neural networks and health economics in decision-making for treatment strategies in advanced colorectal cancer.